Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Mid Cap
Aarti Pharmalabs Ltd.
₹679
Invest in AARTIPHARM with up to 2.50x margin.
Trade with MTF₹675.00
₹697.10
₹585.00
₹971.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 425.25 | 417.29 | 375.31 | 529.62 | 470.95 |
| Operating Expense | 322.31 | 343.31 | 280.18 | 386.50 | 355.96 |
| Operating Profit | 102.94 | 73.98 | 95.13 | 143.13 | 114.99 |
| Depreciation | 28.62 | 24.77 | 22.76 | 20.83 | 21.04 |
| Interest | 12.58 | 10.66 | 6.79 | 6.29 | 9.70 |
| Tax | 14.74 | 10.77 | 15.95 | 24.66 | 22.66 |
| Net Profit | 43.84 | 30.93 | 51.22 | 88.85 | 73.52 |
Research Type
Equity , Long Term
Buy Range
₹733 - ₹751
Target Price
₹868
Stop Loss
-
Target Date
14 Sep 26
Potential Returns
18.42 %
₹679.00
↗ Bullish Moving Average
9
↘ Bearish Moving Average
7
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 46.1 | 44.7 | 44.3 | 43.7 | 42.9 | 43.1 |
| FII | 7.4 | 8.6 | 7.4 | 7.3 | 8 | 7.7 |
| DII | 11.3 | 10.4 | 7.5 | 7.9 | 7 | 7.7 |
| Public | 35.2 | 36.3 | 40.8 | 41.1 | 42.1 | 41.5 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.21 L | 2.7 L | 45.00% |
| Week | 77.7 K | 1.71 L | 45.39% |
| 1 Month | 1.18 L | 2.35 L | 50.27% |
| 6 Month | 1.02 L | 2.18 L | 46.86% |
Benjamin Graham Value Screen
Relative Outperformance versus Industry over 1 Month
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
RSI indicating price strength
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 16 Feb, 2026 | 1.5 | INTERIM | 16 Feb, 2026 | Equity Share |
| 15 Sep, 2025 | 2.5 | FINAL | 15 Sep, 2025 | Equity Share |
| 14 Feb, 2025 | 2.5 | INTERIM | 14 Feb, 2025 | Equity Share |
| 31 Jul, 2024 | 1 | FINAL | 31 Jul, 2024 | Equity Share |
| 16 Feb, 2024 | 2 | INTERIM | 19 Feb, 2024 | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,565 | ₹613.90 | ₹864 | ₹1,370 | ₹4,550 | ₹492.20 |
| % Change | 0.20% | 0.10% | 0.91% | -0.41% | -0.41% | 0.09% |
| Revenue TTM (₹ Cr) | - | - | ₹1,598.19 | ₹1,419.33 | ₹878.40 | ₹4,256.70 |
| Net Profit TTM (₹ Cr) | - | - | ₹206.20 | ₹20.10 | ₹240.10 | ₹318.19 |
| PE TTM | - | - | 68.60 | 784.40 | 43.80 | 24.30 |
| 1 Year Return | 47.07 | 3.42 | 76.54 | -11.44 | -6.21 | 10.23 |
| ROCE | 30.24 | 34.78 | 34.76 | 3.26 | - | 11.27 |
Blue Jet Healthcare Ltd
₹ 370.00
+0.03%
Concord Biotech Ltd.
₹ 1059.00
+0.41%
Piramal Pharma Ltd.
₹ 143.50
+0.38%
Supriya Lifescience Ltd.
₹ 626.70
-0.29%
Acutaas Chemicals Ltd.
₹ 2339.80
+0.76%
Alivus Life Sciences Ltd.
₹ 1040.55
-0.19%
Cohance Lifesciences Ltd.
₹ 320.00
+0.99%
Eris Lifesciences Ltd.
₹ 1364.00
-0.01%
Syngene International Ltd.
₹ 394.50
+0.36%
Alembic Pharmaceuticals Ltd.
₹ 720.00
-0.02%
Strides Pharma Science Ltd.
₹ 995.00
-0.13%
Granules India Ltd.
₹ 634.20
-0.20%
FDC Ltd.
₹ 341.50
+0.26%
Shilpa Medicare Ltd.
₹ 418.65
-0.08%
Jubilant Pharmova Ltd.
₹ 871.85
-0.81%
Caplin Point Laboratories Ltd.
₹ 1659.90
-0.13%
Neuland Laboratories Ltd.
₹ 14726.00
+0.02%
Marksans Pharma Ltd.
₹ 174.90
-0.05%
Sanofi India Ltd.
₹ 3450.00
-0.39%
Procter & Gamble Health Ltd.
₹ 4800.00
-0.04%
Jeena Sikho Lifecare Ltd.
₹ 650.70
-0.02%
By signing up I certify terms, conditions & privacy policy